Page 114

219. Waxman SG. 1998. Demyelinating diseases—new pathological insights, new therapeutic targets. N Engl J Med.; 338: 323-5..

220. Waxman SG. 2000. Multiple sclerosis as a neuronal disease. Arch Neurol.; 57: 22-4..

221. Waxman SG, Black JA, Sontheimer H, Kocsis JD. 1994. Glial cells and axo-glial interactions: implications for demyelinating disorders. Clin Neurosci.; 2: 202-10..

222. Weinshenker BG, Bass B, Rice GP, et al. 1989. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain.; 112: 133-46..

223. Werring DJ, Clark CA, Barker GJ, Thompson AJ, Miller DH. 1999. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology.; 52: 1626-32..

224. Whitacre CC, Reingold SC, O'Looney PA. 1999. A gender gap in autoimmunity. Science.; 283: 1277-8..

225. Williams KC, Ulvestad E, Hickey WF. 1994. Immunology of multiple sclerosis. Clin Neurosci.; 2: 229-45..

226. Wong FS, Dittel BN, Janeway CA Jr. 1999. Transgenes and knockout mutations in animal models of type 1 diabetes and multiple sclerosis. Immunol Rev.; 169: 93-104..

227. Wong FS, Janeway CA Jr. 1999. Insulin-dependent diabetes mellitus and its animal models. Curr Opin Immunol.; 11: 643-647..

228. Wucherpfennig KW, Hafler DA. 1995. A review of T-cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide. Ann N Y Acad Sci 1995 Jul 7;756:241-58.; 756: 241-58..

229. Wucherpfennig KW, Strominger JL. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell.; 80: 695-705..

230. Xu Z, Cork LC, Griffin JW, Cleveland DW. 1993. Involvement of neurofilaments in motor neuron disease. J Cell Sci Suppl.; 17: 101-8..

231. Yamasaki K, Horiuchi I, Minohara M, et al. 1999. HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain.; 122: 1689-96..

232. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med.; 179: 973-84..

233. Zhang J, Stinissen P, Medaer R, Truyen L, Raus J. 1998. T-cell vaccination for the treatment of multiple sclerosis. In Zhang J, editor. Immunotherapy in Neuroimmunologic Diseases. London, England. Martin Dunitz.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement